Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma

NCT00006252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: fludarabine phosphate
DRUG: Cyclophosphamide
BIOLOGICAL: PBSC
DRUG: G-CSF
BIOLOGICAL: Donor lymphocytes

Sponsor

Cancer and Leukemia Group B

Collaborators

[object Object]